Christopher Gabrieli's Net Worth
$19.5 Million
Who is Christopher Gabrieli?
Christopher Gabrieli has an estimated net worth of $19.5 Million. This is based on reported shares across multiple companies, which include AKCEA THERAPEUTICS, INC., ISIS PHARMACEUTICALS INC, BLUE NILE INC, and EPIX Pharmaceuticals, Inc..
SEC CIK
Christopher Gabrieli's CIK is 0001181553
Past Insider Trading and Trends
2004 was Christopher Gabrieli's most active year for acquiring shares with 16 total transactions. Christopher Gabrieli's most active month to acquire stocks was the month of April. 2004 was Christopher Gabrieli's most active year for disposing of shares, totalling 32 transactions. Christopher Gabrieli's most active month to dispose stocks was the month of April. 2005 saw Christopher Gabrieli paying a total of $194,250.00 for 35,000 shares, this is the most they've acquired in one year. In 2004 Christopher Gabrieli cashed out on 5,342,657 shares for a total of $11,090,685.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AKCEA THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ISIS PHARMACEUTICALS INC (IONS) Snapshot price: $49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
$6.55 | -$6,858.00 | 155.43K |
May 14
| |||
Form 4
| -100.00% | -678.00 |
$5.86 | -$3,973.08 |
0
|
Aug 22
| |||
Form 4
| -96.87% | -21.00K |
$5.86 | -$122,992.20 | 678 |
Aug 19 - Aug 20
| |||
Form 4
| -73.26% | -59.40K |
$5.06 | -$300,402.18 | 21.68K |
Jul 24 - Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BLUE NILE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -58.26% | -1.50M |
—
|
—
| 1.07M |
Nov 16
| |||
Form 4/A
| -10.00% | -285.81K |
$20.50 | -$5,859,125.50 | 2.57M |
May 25
| |||
Form 4
| +91.30% | 2.61M |
$20.50 | -$5,097,202.00 | 5.47M |
May 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EPIX Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| -95.58% | -1.37M |
$18.44 | -$447,226.73 | 63.21K |
Aug 12 - Sep 5
| |||
| No matching records found | |||||||||